Sánchez Diego P, Guillén José J, Torres Alberto M, Sánchez Fernando I
Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Murcia, Murcia, España.
Departamento de Ciencias Sociosanitarias, Facultad de Medicina, Universidad de Murcia, Murcia, España.
Aten Primaria. 2014 Mar;46(3):147-55. doi: 10.1016/j.aprim.2013.09.003. Epub 2013 Nov 6.
To estimate the use of cardiovascular medicines and its distribution by age and sex.
Observational study.
Region of Murcia.
Daily doses of cardiovascular drugs prescribed and dispensed in all the pharmacies of the Region per 1,000 inhabitants-day (DHD). A comparison was made of consumption rates (DHD) by age and sex.
The probability of receiving antiplatelet drugs increases with age, with the proportion of men being higher. The use of beta-blockers and angiotensin II increases with age up to 79 years, with an increased consumption in men up to 65 years. The probability of receiving treatment with calcium channel blockers, ACE inhibitors, or statins, linearly increases with age, and the proportion of men under treatment exceeds that of women in the early ages, tending to equalize beyond 80 years.
This study shows that the cardiovascular disease prevention focuses on people aged 40 to 74 years. Access by women to cardiovascular therapy occurs with a delay of 3-5 years, depending on the treatment subgroup. Changes should be promoted to encourage rational and equitable access and use of the drugs.
评估心血管药物的使用情况及其按年龄和性别分布情况。
观察性研究。
穆尔西亚地区。
该地区所有药店每1000居民日(DHD)开具和配发的心血管药物日剂量。对按年龄和性别划分的消费率(DHD)进行了比较。
服用抗血小板药物的概率随年龄增加,男性比例更高。β受体阻滞剂和血管紧张素II的使用随年龄增长至79岁增加,男性在65岁前消费量增加。接受钙通道阻滞剂、ACE抑制剂或他汀类药物治疗的概率随年龄线性增加,早期接受治疗的男性比例超过女性,80岁以后趋于相等。
本研究表明,心血管疾病预防重点关注40至74岁人群。女性获得心血管治疗会延迟3至5年,具体取决于治疗亚组。应推动变革,以鼓励合理、公平地获取和使用药物。